Background: This paper describes the synthesis of three different subfamilies of cyclic imides: methylphtalimides, carboxyl acid phtalimides and itaconimides. Methods: Fifteen compounds (five of each sub-family) were obtained by the reaction of appropriated anhydrides and different aromatic amines, using the manual Topliss method. Their structures were confirmed by spectral data (IR and NMR). The antifungal activity of the synthesized compounds was investigated by broth microdilution to determine the minimal inhibitory concentration (MIC). The ability to inhibit the biofilm formation or destroy mature Candida albicans biofilm was also evaluated for the most active substances. Results: The results indicated that only the itaconimides 11-15 exhibited potent and promising antifungal properties, with MIC100 between 1 and 64 mu g mL(-1), being several times more potent than the reference drug, Fluconazole. Compounds 11-15 inhibited between 64% and 95% of biofilm formation, and destroyed between 78% and 99% of mature biofilm at a concentration of 64 mu g mL(-1). ADME (absorption, distribution, metabolism and excretion) in silico evaluations were carried out to predict whether the molecules under study are good drug candidates. Conclusions: Itaconimides appear to be promising and relevant as tools for the future development of new and effective medicinal agents to treat fungal diseases.

Synthesis of cyclic imides (methylphtalimides, carboxylic acid phtalimides and itaconimides) and evaluation of their antifungal potential / Stiz, Dorimar; Corrêa, Rogério; D'Auria, Felicia Diodata; Simonetti, Giovanna; Cechinel Filho, Valdir. - In: MEDICINAL CHEMISTRY. - ISSN 1573-4064. - ELETTRONICO. - 12:7(2016), pp. 1-8. [10.2174/1573406412666160229150833]

Synthesis of cyclic imides (methylphtalimides, carboxylic acid phtalimides and itaconimides) and evaluation of their antifungal potential

D'AURIA, Felicia Diodata;SIMONETTI, Giovanna;
2016

Abstract

Background: This paper describes the synthesis of three different subfamilies of cyclic imides: methylphtalimides, carboxyl acid phtalimides and itaconimides. Methods: Fifteen compounds (five of each sub-family) were obtained by the reaction of appropriated anhydrides and different aromatic amines, using the manual Topliss method. Their structures were confirmed by spectral data (IR and NMR). The antifungal activity of the synthesized compounds was investigated by broth microdilution to determine the minimal inhibitory concentration (MIC). The ability to inhibit the biofilm formation or destroy mature Candida albicans biofilm was also evaluated for the most active substances. Results: The results indicated that only the itaconimides 11-15 exhibited potent and promising antifungal properties, with MIC100 between 1 and 64 mu g mL(-1), being several times more potent than the reference drug, Fluconazole. Compounds 11-15 inhibited between 64% and 95% of biofilm formation, and destroyed between 78% and 99% of mature biofilm at a concentration of 64 mu g mL(-1). ADME (absorption, distribution, metabolism and excretion) in silico evaluations were carried out to predict whether the molecules under study are good drug candidates. Conclusions: Itaconimides appear to be promising and relevant as tools for the future development of new and effective medicinal agents to treat fungal diseases.
2016
cyclic imides; synthesis; antifungal activity; candida biofilm; structure-activity relationships
01 Pubblicazione su rivista::01a Articolo in rivista
Synthesis of cyclic imides (methylphtalimides, carboxylic acid phtalimides and itaconimides) and evaluation of their antifungal potential / Stiz, Dorimar; Corrêa, Rogério; D'Auria, Felicia Diodata; Simonetti, Giovanna; Cechinel Filho, Valdir. - In: MEDICINAL CHEMISTRY. - ISSN 1573-4064. - ELETTRONICO. - 12:7(2016), pp. 1-8. [10.2174/1573406412666160229150833]
File allegati a questo prodotto
File Dimensione Formato  
Stiz_Synthesis_2016.pdf

solo gestori archivio

Note: Articolo principale
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 183.15 kB
Formato Adobe PDF
183.15 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/958828
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 15
social impact